Skip to content
Abierto

Award notice, first published as presolicitation

Lurasidone HCL Tablets Major Pharmaceuticals - 12/10/2024 - 12/9/2025

36E79724R0022

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

Awarded

The Harvard Drug Group, L.L.C.

$10,056,938.10 on the award notice, October 10, 2024, contract 36E79725D0001

Description

As published on SAM.gov.

N/A

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
CBGGKKVNJBK9
CAGE
1LEZ0
Vendor location
La Vergne, TN
Contract
36E79725D0001
Obligated
$0.00, potential $10,056,938
Actions
5 between October 10, 2024 and August 31, 2026
Competition
Full and Open Competition, 5 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Lurasidone HCL Tablets with the Harvard Drug Group, L.L.C. DBA Major Pharmaceuticals. Base Year Ordering Period Is 12/10/2024 to 12/09/2025 with Four ONE-YEAR Options.
Match
solicitation number 36E79724R0022 equals the FPDS solicitation identifier; same awarding office 36E797 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 16, 2024

    Presolicitation

    Lurasidone Tablets (VA-24-00084543)

    Due August 16, 2024 at 3:30 PM EDT. SAM.gov, notice 891773702b01458c9c344cc49a1801a3

  2. July 29, 2024

    Solicitation, originally presolicitation

    Lurasidone Tablets (VA-24-00084543)

    Due August 16, 2024 at 3:30 PM EDT. SAM.gov, notice 07fa2d38f5db4cfc953c064b7bb79a14

  3. August 13, 2024

    Solicitation

    Lurasidone Tablets (VA-24-00084543)

    Due August 26, 2024 at 3:30 PM EDT. SAM.gov, notice 4d8c733cd9a04285a69836ceb6de89d9

  4. October 10, 2024

    Award notice

    Awarded to The Harvard Drug Group, L.L.C. LA VERGNE 37086 for $10,056,938. SAM.gov, notice 2feace4042b04fca8a201deb961eb04f

Points of contact